Insufficient scRNA-seq data for expression of PYDC2 at single-cell level.
Insufficient scRNA-seq data for expression of PYDC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| bladder | 14% | 0.24 | 3 / 21 | 1% | 0.02 | 5 / 504 |
| adrenal gland | 7% | 0.10 | 17 / 258 | 0% | 0 | 0 / 230 |
| lung | 4% | 0.05 | 21 / 578 | 1% | 0.02 | 13 / 1155 |
| ovary | 4% | 0.05 | 7 / 180 | 0% | 0.00 | 1 / 430 |
| esophagus | 2% | 0.04 | 28 / 1445 | 2% | 0.06 | 3 / 183 |
| adipose | 4% | 0.05 | 43 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
| blood vessel | 3% | 0.05 | 45 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 3% | 0.03 | 8 / 241 | 0% | 0 | 0 / 0 |
| breast | 3% | 0.06 | 14 / 459 | 0% | 0.00 | 1 / 1118 |
| uterus | 3% | 0.04 | 5 / 170 | 0% | 0 | 0 / 459 |
| heart | 3% | 0.04 | 25 / 861 | 0% | 0 | 0 / 0 |
| brain | 2% | 0.03 | 62 / 2642 | 0% | 0 | 0 / 705 |
| skin | 2% | 0.03 | 33 / 1809 | 0% | 0.01 | 2 / 472 |
| stomach | 1% | 0.02 | 5 / 359 | 1% | 0.01 | 2 / 286 |
| intestine | 2% | 0.02 | 15 / 966 | 0% | 0.00 | 2 / 527 |
| liver | 2% | 0.03 | 4 / 226 | 0% | 0 | 0 / 406 |
| peripheral blood | 1% | 0.02 | 12 / 929 | 0% | 0 | 0 / 0 |
| kidney | 1% | 0.02 | 1 / 89 | 0% | 0.00 | 1 / 901 |
| pancreas | 1% | 0.01 | 2 / 328 | 1% | 0.02 | 1 / 178 |
| thymus | 1% | 0.02 | 7 / 653 | 0% | 0 | 0 / 605 |
| prostate | 1% | 0.01 | 2 / 245 | 0% | 0.00 | 1 / 502 |
| muscle | 1% | 0.02 | 8 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0050728 | Biological process | negative regulation of inflammatory response |
| GO_0006954 | Biological process | inflammatory response |
| GO_0010804 | Biological process | negative regulation of tumor necrosis factor-mediated signaling pathway |
| GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
| GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
| GO_1900226 | Biological process | negative regulation of NLRP3 inflammasome complex assembly |
| GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
| GO_0045087 | Biological process | innate immune response |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PYDC2 |
| Protein name | Pyrin domain-containing protein 2 (Pyrin-only protein 2) (cellular POP2) (cPOP2) |
| Synonyms | POP2 |
| Description | FUNCTION: May play a role in innate immunity by disrupting the interaction between PYCARD and NLRP3, thereby regulating the NLRP3 inflammasome . May also inhibit NF-kappa-B signaling distally by affecting the nuclear accumulation of RELA . . |
| Accessions | Q56P42 ENST00000518817.1 |